N-Fmoc-O-(trifluoromethyl)-L-tyrosine introduces a strongly electron-withdrawing group to the tyrosine ring. The modification alters polarity, aromaticity, and hydrogen-bonding potential. Researchers use it to study fluorine-driven interactions and modified spectroscopic signatures. Its Fmoc protection aids precise incorporation.
CAT No: R2113
CAS No:1260614-87-6
Synonyms/Alias:N-Fmoc-O-(trifluoromethyl)-L-tyrosine;1260614-87-6;(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-(trifluoromethoxy)phenyl)propanoic acid;FMOC-TYR(CF3)-OH;(2S)-2-{[(9H-FLUOREN-9-YLMETHOXY)CARBONYL]AMINO}-3-[4-(TRIFLUOROMETHOXY)PHENYL]PROPANOIC ACID;Fmoc-L-Phe(4-OCF3)-OH;SCHEMBL25178687;Fmoc-O-(trifluoromethyl)-L-tyrosine;MFCD07371983;CS-0357471;F80042;(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-[4-(trifluoromethoxy)phenyl]propanoic acid;
2. High fat diet and GLP-1 drugs induce pancreatic injury in mice
4. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry
5. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More